Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

Clinical trial NCT06315231 · RECRUITING

Trial details

NCT number: NCT06315231
Sponsor: Simcere Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Post-stroke Cognitive Impairment

Start date: 2024-04-08
Primary completion: 2026-12-30
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.